BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge technology and innovative research to develop high-value therapeutics aimed at transforming patients’ lives. BioXcel Therapeutics employs a unique AI platform to reduce therapeutic development costs and potentially accelerate timelines while aiming to increase the possibility of success.